ATF6 is Required for ANP Secretion from the Heart
ATF6 是心脏分泌 ANP 所必需的
基本信息
- 批准号:10219762
- 负责人:
- 金额:$ 34.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-12-15 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:ATF6 geneAcuteAddressAdultAffectAntioxidantsAtrial Natriuretic FactorBiological ModelsBlood PressureBlood VolumeCalciumCardiacCardiac MyocytesCardiovascular PhysiologyCardiovascular systemCell NucleusCell membraneCellsCessation of lifeChronicCleaved cellCoupledCytoplasmic GranulesDataDevelopmentDockingElementsEnsureExcretory functionFoundationsGene DeletionGene ExpressionGenesGoalsGolgi ApparatusGrowth Factor ReceptorsHeartHeart AtriumHeart failureHormone secretionHormonesHypertensionIon ChannelIschemiaLinkMammalian CellMissionModelingMorbidity - disease rateMusMuscle CellsOrganOxidative StressPathologicPathway interactionsPlasmaPlayProteinsPublic HealthQuality ControlResearchRoleRough endoplasmic reticulumRouteSNAP receptorSNAP23 geneSecretory VesiclesSiteStretchingTimeTissuesTransgenic MiceUnited States National Institutes of HealthVasodilationVentricularbasecardiovascular effectscell typedesigndietaryendoplasmic reticulum stressgain of functionhemodynamicsin vivoinnovationloss of functionmisfolded proteinmortalitymouse modelnovelnovel strategiesnovel therapeuticspeptide hormonepressureprogramsprotein foldingprotein functionprotein misfoldingsalt sensitive hypertensionsmall moleculetranscription factortranscriptome
项目摘要
Project Summary
ER protein misfolding is sensed in the rough ER by ATF6, which is expressed in all mammalian cells. We
previously showed that in ventricular myocytes, in vivo, ischemia causes ER protein misfolding, which is
sensed by ATF6, converting it to a transcription factor that induces antioxidant genes that were not known to
be ATF6-regulated in any cell type. Our objective here is to study a new role for ATF6 as a critical element in
regulated secretion, focusing on atrial natriuretic peptide (ANP), a peptide hormone made in the ER of atrial
myocytes. Neither the function of ATF6 in the atria, nor its role in regulated hormone secretion has been
studied. Therefore, this proposal addresses a novel role for ATF6 as a linchpin in regulated hormone secretion
using a cardiac model system that we call the ATF6-ANP axis. Our preliminary data showed that under non-
stressed conditions, in contrast to ventricular cell and tissue, activated ATF6 was found in atrial cell and tissue,
even in the absence of ER stress. While activated ATF6 did not increase ANP gene expression in the atria, it
was required for ANP secretion from atrial myocytes. Mechanistically, we found that ATF6 induced several
secretory pathway proteins that were not previously known to be ATF6-regulated and have not been studied in
the heart, including the SNARE protein, SNAP23. SNAP23 is known to enhance granule docking and secretion
in other cell types. Based on this background and preliminary data, our hypothesis is that ATF6 is essential
for the secretion and beneficial cardiovascular (CV) effects of ANP. SNAP23 is a mechanistic link between
ATF6 and regulated ANP secretion. We will address this hypothesis in three specific aims, which are to: 1-
examine the effects of AAV9- and small molecule-based ATF6 gain-of-function, and conditional ATF6 gene
deletion maneuvers on ANP secretion from atrial myocytes and mouse hearts, 2-determine how ATF6 gain-
and loss-of-function affects plasma ANP and hemodynamic parameters in mouse models of dietary high-salt-
induced hypertension and pressure overload-induced heart failure, and 3-define the mechanistic role of the
ATF6-inducible secretory granule docking protein, SNAP23, in ANP secretion from cultured atrial myocytes
and mouse hearts.
项目摘要
ATF6在粗糙的ER中检测到ER蛋白的折叠率错折叠,这在所有哺乳动物细胞中均表达。我们
以前表明,在体内的心肌细胞中,缺血会导致ER蛋白质折叠,这是
通过ATF6感应,将其转化为转录因子,该转录因子诱导抗氧化基因
在任何细胞类型中都受到ATF6调节。我们的目的是研究ATF6作为关键要素的新角色
受调节的分泌,重点放在心房尿液肽(ANP)上
心肌细胞。 ATF6在心房中的功能既不是其在受调节激素分泌中的作用
研究。因此,该提案解决了ATF6作为linchpin的新作用
使用我们称为ATF6-ANP轴的心脏模型系统。我们的初步数据表明,在非 -
与心室细胞和组织相反,应力条件在心房细胞和组织中发现了ATF6,
即使没有ER应力。虽然激活的ATF6并未增加心房中的ANP基因表达,但
是对心肌细胞的ANP分泌所必需的。从机械上讲,我们发现ATF6诱导了几个
分泌途径蛋白以前尚不知道ATF6调节且尚未在
心脏,包括军鼓蛋白,snap23。已知SNAP23可以增强颗粒对接和分泌物
在其他细胞类型中。基于此背景和初步数据,我们的假设是ATF6是必不可少的
对于ANP的分泌和有益的心血管(CV)效应。 SNAP23是一种机械联系
ATF6并规范ANP分泌。我们将以三个特定目标来解决这一假设,该假设是:1-
检查基于AAV9和小分子的ATF6功能获得的效果,以及条件ATF6基因
从心肌细胞和小鼠心脏分泌ANP分泌的删除操作,2确定ATF6如何增益 -
功能丧失会影响血浆ANP和血液动力学参数
诱导的高血压和压力超负荷引起的心力衰竭,三定义
ATF6诱导的分泌颗粒对接蛋白Snap23在培养的心房肌细胞的ANP分泌中
和鼠标的心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chris Glembotski其他文献
Chris Glembotski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chris Glembotski', 18)}}的其他基金
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10544178 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10363838 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10817347 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10550149 - 财政年份:2020
- 资助金额:
$ 34.54万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
10227351 - 财政年份:2020
- 资助金额:
$ 34.54万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10322459 - 财政年份:2020
- 资助金额:
$ 34.54万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10218914 - 财政年份:2020
- 资助金额:
$ 34.54万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
9389978 - 财政年份:2017
- 资助金额:
$ 34.54万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
9924642 - 财政年份:2017
- 资助金额:
$ 34.54万 - 项目类别:
Role of the SR/ER E3 Ubiquitin Ligase Synoviolin 1 in Cardiac Hypertrophy
SR/ER E3 泛素连接酶 Synoviolin 1 在心脏肥大中的作用
- 批准号:
9102175 - 财政年份:2015
- 资助金额:
$ 34.54万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Development of a novel therapeutic agent that exploits specific vulnerabilities in claudin low breast cancer
开发一种利用 Claudin 低乳腺癌特定弱点的新型治疗剂
- 批准号:
9886204 - 财政年份:2017
- 资助金额:
$ 34.54万 - 项目类别: